register

Digital & Innovation

Telstra Health acquires GP prescribing software for $350M

Health Industry Hub | August 11, 2021 |

Digital & Innovation: Telstra Health announced plans to acquire the leading GP clinical and practice management software company MedicalDirector for $350M, taking a key step in our vision to create a connected and improved digital health experience for all.

Telstra Health Board Chair Brendon Riley said the acquisition of MedicalDirector was a key step in Telstra Health’s vision to create a connected and improved digital health experience for all.

“MedicalDirector is a modern clinical and practice management solution that supports GPs and other medical specialists to focus on providing high-quality care and reducing time on paperwork and administration. It supports consultations by medical practitioners through a comprehensive patient medical record, including electronic prescriptions, options for virtual consultations, patient care plans, real-time alerts about drug safety and drug interaction, and a range of other functionalities,” Mr Riley said.

“GPs play a central role in connecting to every part of the health and aged care systems, and practice management is an incredibly important addition for Telstra Health in providing quality solutions and supporting them to deliver care. Telstra Health has transformed substantially over the past five years and this announcement reflects its continuing maturity as a business and its importance as part of Telstra’s long-term growth strategy. It also reflects its continued growth into a global business, including strengthening our existing presence in the UK where MedicalDirector has been establishing itself in recent years.”

MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, medicines information, and clinical content. Its SaaS solutions support general practitioners and other specialists and pharmacies in the Australian healthcare industry. It currently supports approximately 23,000 medical practitioners and is used to deliver more than 80 million consultations a year.

Telstra Health’s Managing Director, Professor Mary Foley AM, said the acquisition supported Telstra Health’s vision to be a leading partner to the health and aged care sectors.

“Patient care journeys move back and forth across home, clinics, hospitals, aged-care, and pharmacies. This acquisition helps realise our vision to connect and co-ordinate across the continuum of care, enabling smoother experiences for those who need it and provide it.”

“Digital solutions support operational efficiency and effectiveness and help clinicians and other care providers solve some of the complex problems they face in the delivery of care.”

“We will significantly increase investment in MedicalDirector to provide medical practitioners with the best digital solutions, across desktop and cloud, to support the future delivery of primary health care.

“I am excited about the opportunity to continue to grow MedicalDirector, combining its sophisticated solutions with Telstra Health’s clinical and health system capabilities, including our expert team of medical practitioners (including GPs), health information managers, and other health experts.”

MedicalDirector’s CEO, Matthew Bardsley, said “The team here at MedicalDirector are very excited about this announcement today. The ability to bring our knowledge, trusted industry-leading products, and our team to support the vision of Telstra Health is recognition of the great business we have built.

We look forward to working with Telstra Health to help support the critical work of the healthcare industry through innovation and technology, never more so important than right now. Thank you to all of our customers who are on the front line providing critical services during this pandemic. Together with Telstra Health, we will continue to provide you with all the support we can to help keep all Australians safe at this time.”

MedicalDirector is being acquired from funds advised by Affinity Equity Partners, with the transaction expected to complete in Q1 FY22.


Medical

NSW Health to settle class action

NSW Health to settle ‘largest’ class action

Health Industry Hub | April 29, 2024 |

A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]

More


News & Trends - Pharmaceuticals

Lilly's first-in-class therapy PBS listed for early breast cancer after 15-year gap

Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap

Health Industry Hub | April 29, 2024 |

Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]

More


News & Trends - Pharmaceuticals

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

Health Industry Hub | April 29, 2024 |

Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]

More


News & Trends - Pharmaceuticals

PBAC recommendation to reshape prescribing in heart failure

PBAC recommendation to reshape prescribing in heart failure

Health Industry Hub | April 29, 2024 |

Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]

More


This content is copyright protected. Please subscribe to gain access.